Literature DB >> 11162117

Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.

M A McCoy1, M M Senior, J J Gesell, L Ramanathan, D F Wyss.   

Abstract

The backbone assignments, secondary structure, topology, and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex have been determined by NMR spectroscopy. Residues I34 to S181 of NS3 and the central three residues of the NS4A cofactor were assigned and the secondary structure was verified for these residues. In several X-ray structures of NS4A-bound NS3 protease, residues 1 to 28 are stabilized by crystal packing, which allows for the formation of the A0 strand and alpha0 helix. In solution, these N-terminal residues are largely unassigned and no evidence of a well-structured A0 strand or alpha0 helix was detected. NOEs between residues in the E1-F1 loop (containing D81) and the alpha1 helix (containing H57) together with the detection of a D81-H57 hydrogen bond indicate that in solution the catalytic triad (D81, H57, S139) of the protease is better ordered in the presence of the NS4A cofactor. This is consistent with the earlier crystallographic results and may explain the observed increase in catalytic activity of the enzyme due to NS4A binding. A model-free analysis of our relaxation data indicates substantial exchange rates for residues V51-D81, which comprise the upper part of the N-terminal beta-barrel. A comparison of chemical-shift differences between NS3 protease and the NS3 protease-NS4A complex shows extensive chemical-shift changes for residues V51-D81 indicating that non-local structural changes occur upon NS4A binding to the NS3 protease that are propagated well beyond the protease-cofactor interaction site. This is consistent with crystallographic data that reveal large structural rearrangements of the strand and loop regions formed by residues V51-D81 as a result of NS4A binding. The coincidence of large exchange rates for the NS3 protease-NS4A complex with chemical-shift differences due to NS4A binding suggests that residues V51-D81 of the NS3 protease NS4A complex are in slow exchange with a NS4A-free conformation of NS3 protease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162117     DOI: 10.1006/jmbi.2000.4365

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335.

Authors:  Christopher T Lemke; Nathalie Goudreau; Songping Zhao; Oliver Hucke; Diane Thibeault; Montse Llinàs-Brunet; Peter W White
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

2.  The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.

Authors:  Annarita Casbarra; Fabrizio Dal Piaz; Paolo Ingallinella; Stefania Orrù; Piero Pucci; Antonello Pessi; Elisabetta Bianchi
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

3.  NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition.

Authors:  Munia Mukherjee; Kaushik Dutta; Mark A White; David Cowburn; Robert O Fox
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

4.  Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication.

Authors:  René Assenberg; Eloise Mastrangelo; Thomas S Walter; Anil Verma; Mario Milani; Raymond J Owens; David I Stuart; Jonathan M Grimes; Erika J Mancini
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

5.  Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.

Authors:  Pornwaratt Niyomrattanakit; Pakorn Winoyanuwattikun; Santad Chanprapaph; Chanan Angsuthanasombat; Sakol Panyim; Gerd Katzenmeier
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor.

Authors:  Caterina Trozzi; Linda Bartholomew; Alessandra Ceccacci; Gabriella Biasiol; Laura Pacini; Sergio Altamura; Frank Narjes; Ester Muraglia; Giacomo Paonessa; Uwe Koch; Raffaele De Francesco; Christian Steinkuhler; Giovanni Migliaccio
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  HCV genetics and genotypes dictate future antiviral strategies.

Authors:  Louis Papageorgiou; Chrisanthy Vlachakis; Konstantina Dragoumani; Sofia Raftopoulou; Dimitrios Brouzas; Nicolas C Nicolaides; George P Chrousos; Evangelia Charmandari; Vasileios Megalooikonomou; Dimitrios Vlachakis
Journal:  J Mol Biochem       Date:  2017-12-10

8.  Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease.

Authors:  Nicola J Baxter; Andreas Roetzer; Hans-Dieter Liebig; Svetlana E Sedelnikova; Andrea M Hounslow; Tim Skern; Jonathan P Waltho
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus.

Authors:  Christoph Welsch; Francisco S Domingues; Simone Susser; Iris Antes; Christoph Hartmann; Gabriele Mayr; Andreas Schlicker; Christoph Sarrazin; Mario Albrecht; Stefan Zeuzem; Thomas Lengauer
Journal:  Genome Biol       Date:  2008-01-23       Impact factor: 13.583

10.  Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors.

Authors:  Wengang Yang; Yongsen Zhao; Joanne Fabrycki; Xiaohong Hou; Xingtie Nie; Amy Sanchez; Avinash Phadke; Milind Deshpande; Atul Agarwal; Mingjun Huang
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.